These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Antimicrobial activity of synthetic cationic peptides and lipopeptides derived from human lactoferricin against Pseudomonas aeruginosa planktonic cultures and biofilms. Sánchez-Gómez S; Ferrer-Espada R; Stewart PS; Pitts B; Lohner K; Martínez de Tejada G BMC Microbiol; 2015 Jul; 15():137. PubMed ID: 26149536 [TBL] [Abstract][Full Text] [Related]
3. Lactoferrin-derived peptides and Lactoferricin chimera inhibit virulence factor production and biofilm formation in Pseudomonas aeruginosa. Xu G; Xiong W; Hu Q; Zuo P; Shao B; Lan F; Lu X; Xu Y; Xiong S J Appl Microbiol; 2010 Oct; 109(4):1311-8. PubMed ID: 20477900 [TBL] [Abstract][Full Text] [Related]
4. Critical Assessment of Methods to Quantify Biofilm Growth and Evaluate Antibiofilm Activity of Host Defence Peptides. Haney EF; Trimble MJ; Cheng JT; Vallé Q; Hancock REW Biomolecules; 2018 May; 8(2):. PubMed ID: 29883434 [TBL] [Abstract][Full Text] [Related]
5. Antibiofilm activities of lactoferricin-related Trp- and Arg-rich antimicrobial hexapeptides against pathogenic Staphylococcus aureus and Pseudomonas aeruginosa strains. Ramamourthy G; Vogel HJ Biochem Cell Biol; 2024 Oct; ():. PubMed ID: 39418670 [TBL] [Abstract][Full Text] [Related]
6. Identification of peptides derived from the human antimicrobial peptide LL-37 active against biofilms formed by Pseudomonas aeruginosa using a library of truncated fragments. Nagant C; Pitts B; Nazmi K; Vandenbranden M; Bolscher JG; Stewart PS; Dehaye JP Antimicrob Agents Chemother; 2012 Nov; 56(11):5698-708. PubMed ID: 22908164 [TBL] [Abstract][Full Text] [Related]
7. Design SMAP29-LysPA26 as a Highly Efficient Artilysin against Pseudomonas aeruginosa with Bactericidal and Antibiofilm Activity. Wang T; Zheng Y; Dai J; Zhou J; Yu R; Zhang C Microbiol Spectr; 2021 Dec; 9(3):e0054621. PubMed ID: 34878337 [TBL] [Abstract][Full Text] [Related]
8. A Novel RNase 3/ECP Peptide for Pseudomonas aeruginosa Biofilm Eradication That Combines Antimicrobial, Lipopolysaccharide Binding, and Cell-Agglutinating Activities. Pulido D; Prats-Ejarque G; Villalba C; Albacar M; González-López JJ; Torrent M; Moussaoui M; Boix E Antimicrob Agents Chemother; 2016 Oct; 60(10):6313-25. PubMed ID: 27527084 [TBL] [Abstract][Full Text] [Related]
9. Lactoferrampin: a novel antimicrobial peptide in the N1-domain of bovine lactoferrin. van der Kraan MI; Groenink J; Nazmi K; Veerman EC; Bolscher JG; Nieuw Amerongen AV Peptides; 2004 Feb; 25(2):177-83. PubMed ID: 15062998 [TBL] [Abstract][Full Text] [Related]
10. Structural features governing the activity of lactoferricin-derived peptides that act in synergy with antibiotics against Pseudomonas aeruginosa in vitro and in vivo. Sánchez-Gómez S; Japelj B; Jerala R; Moriyón I; Fernández Alonso M; Leiva J; Blondelle SE; Andrä J; Brandenburg K; Lohner K; Martínez de Tejada G Antimicrob Agents Chemother; 2011 Jan; 55(1):218-28. PubMed ID: 20956602 [TBL] [Abstract][Full Text] [Related]
11. Combination of hypothiocyanite and lactoferrin (ALX-109) enhances the ability of tobramycin and aztreonam to eliminate Pseudomonas aeruginosa biofilms growing on cystic fibrosis airway epithelial cells. Moreau-Marquis S; Coutermarsh B; Stanton BA J Antimicrob Chemother; 2015 Jan; 70(1):160-6. PubMed ID: 25213272 [TBL] [Abstract][Full Text] [Related]
12. 3,6-Di(pyridin-2-yl)-1,2,4,5-tetrazine (pytz)-capped silver nanoparticles (TzAgNPs) inhibit biofilm formation of Pseudomonas aeruginosa: a potential approach toward breaking the wall of biofilm through reactive oxygen species (ROS) generation. Chakraborty P; Joardar S; Ray S; Biswas P; Maiti D; Tribedi P Folia Microbiol (Praha); 2018 Nov; 63(6):763-772. PubMed ID: 29855854 [TBL] [Abstract][Full Text] [Related]
13. Synthetic dendrimeric peptide active against biofilm and persister cells of Pseudomonas aeruginosa. Bahar AA; Liu Z; Totsingan F; Buitrago C; Kallenbach N; Ren D Appl Microbiol Biotechnol; 2015 Oct; 99(19):8125-35. PubMed ID: 26012420 [TBL] [Abstract][Full Text] [Related]
14. Antibacterial spectrum of lactoferricin B, a potent bactericidal peptide derived from the N-terminal region of bovine lactoferrin. Bellamy W; Takase M; Wakabayashi H; Kawase K; Tomita M J Appl Bacteriol; 1992 Dec; 73(6):472-9. PubMed ID: 1490908 [TBL] [Abstract][Full Text] [Related]
16. Synergistic and antibiofilm activity of the antimicrobial peptide P5 against carbapenem-resistant Pseudomonas aeruginosa. Martinez M; Gonçalves S; Felício MR; Maturana P; Santos NC; Semorile L; Hollmann A; Maffía PC Biochim Biophys Acta Biomembr; 2019 Jul; 1861(7):1329-1337. PubMed ID: 31095945 [TBL] [Abstract][Full Text] [Related]
17. In vitro pharmacokinetics/pharmacodynamics of continuous ceftazidime infusion alone and in combination with colistin against Pseudomonas aeruginosa biofilm. Gómez-Junyent J; Murillo O; Yu HH; Azad MAK; Wickremasinghe H; Rigo-Bonnin R; Benavent E; Ariza J; Li J Int J Antimicrob Agents; 2021 Feb; 57(2):106246. PubMed ID: 33253904 [TBL] [Abstract][Full Text] [Related]
18. Antibacterial, anti-biofilm and in vivo activities of the antimicrobial peptides P5 and P6.2. Martínez M; Polizzotto A; Flores N; Semorile L; Maffía PC Microb Pathog; 2020 Feb; 139():103886. PubMed ID: 31778756 [TBL] [Abstract][Full Text] [Related]
19. Targeting antibiotic tolerance in anaerobic biofilms associated with oral diseases: Human antimicrobial peptides LL-37 and lactoferricin enhance the antibiotic efficacy of amoxicillin, clindamycin and metronidazole. Wuersching SN; Huth KC; Hickel R; Kollmuss M Anaerobe; 2021 Oct; 71():102439. PubMed ID: 34454095 [TBL] [Abstract][Full Text] [Related]
20. Structural studies and model membrane interactions of two peptides derived from bovine lactoferricin. Nguyen LT; Schibli DJ; Vogel HJ J Pept Sci; 2005 Jul; 11(7):379-89. PubMed ID: 15635665 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]